시장보고서
상품코드
1264788

COVID-19 검사 시장(2023년)

COVID-19 Testing Markets, 2023

발행일: | 리서치사: Kalorama Information | 페이지 정보: 영문 131 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

COVID-19 검사 시장에 대해 조사했으며, 시장의 개요와 부문별 동향 및 진출 기업의 개요와 제품 개요 등을 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 서론

제3장 문제와 동향

제4장 COVID-19의 면역분석법 검사

  • 개요
  • 효소면역측정법(ELISA)
  • 질량분석
  • 급속
  • 제품
  • 항원
  • 항체
  • 시장 규모와 성장
  • 경쟁 시장 점유율

제5장 COVID-19의 분자 검사

  • 개요
  • 제품
  • 시장 규모와 성장
  • 경쟁 시장 점유율

제6장 COVID-19 검사 시장의 개요

제7장 시장 참여 기업

  • Abbott
  • Access Bio, Inc
  • Becton-Dickinson
  • BioMérieux
  • Bio-Rad
  • Cue Health
  • Danaher Corporation
  • DiaSorin S.p.A.
  • ELITech Group S.A.S
  • Genedrive plc
  • Hologic, Inc
  • LumiraDx UK Limited
  • OraSure Technologies, Inc.
  • PerkinElmer, Inc
  • QIAGEN N.V.
  • QuantuMDx Group, Ltd
  • QuidelOrtho Corporation
  • Roche Diagnostic Corporation
  • Seegene, Inc
  • Siemens Healthineers GmbH
  • Snibe Co. Ltd(Shenzhen New Industries Biomedical Engineering Co)
  • ThermoFisher Scientific
KSA 23.05.04

COVID-19 testing has been at the forefront in battling the pandemic. However, as the pandemic recedes and becomes more endemic, what will happen to the ever-changing COVID-19 testing market? Kalorama Information answers this question and more in “COVID-19 Testing Markets, 2023”.

The pandemic has been a learning curve for all parties to invest in diagnostic systems, as COVID-19 aptly pointed out. Notably, the pandemic reinforced the importance of testing and a significant number of companies are increasing their development of a wide selection of diagnostic tests in all markets. Diagnostics have been critical in the response to COVID-19.

This report provides market sizing and estimates for COVID-19 tests with discussion of market impacts of COVID-19.

Some of the key topics and trends explored include:

  • At-Home Testing
  • Insurance Coverage
  • Multiplex Testing
  • Expiration of Public Health Emergency
  • New Variants on the Horizon
  • Immunoassay Testing
  • Molecular Testing

Global Regional Analysis

The report's global analysis features research, such as 2022-2027 sales estimates and forecasts, for regions and countries including:

  • APAC
  • Europe
  • North America
  • Rest of World
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • Denmark
  • France
  • Germany
  • India
  • Italy
  • Mexico
  • Netherlands
  • Japan
  • Poland
  • Romania
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • United States

Competitive Analysis

The report includes analysis and profiles of key companies competing in this industry, including a breakout of the top competitors in the COVID-19 testing market based on 2022 manufacturer revenues.

Companies profiled include:

  • Abbott
  • Access Bio, Inc
  • Becton-Dickinson
  • BioMérieux
  • Bio-Rad
  • Cue Health
  • Danaher corporation
  • Diasorin
  • ELITechGroup
  • Genedrive plc
  • Hologic
  • LumiraDx UK
  • OraSure Technologies
  • PerkinElmer, Inc
  • Qiagen
  • QuantuMDx
  • QuidelOrtho
  • Roche Diagnostic Corporation
  • Seegene
  • Siemens Healthineers
  • Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
  • Thermo Fisher Scientific

Scope and Methodology

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews, in-person interviews and email correspondence were the primary methods of gathering information. For the purpose of this study, Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers' level. The market includes manufacturer tests. The base year for data was 2022. Data are provided for 2022 and 2027 with compound annual growth rates (CAGRs) for 2022 and 2027. Competitive analysis is provided for the top ten participants in the market. Regional breakdowns are surveyed for North America, Europe, Asia-Pacific and Rest of World. The forecasted market analysis through 2027 was largely based on demographic trends, new developments, trajectory of COVID-19 and its variants, innovative technology and global use.

Table of Contents

Chapter 1: Executive Summary

  • Industry at a Glance
  • Scope and Methodology
  • Size and Growth of the Market
    • Table 1-1: Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales by Segment, 2022-2027
    • Figure 1-1: Global COVID-19 Market by Key Segment (Molecular, Immunoassay), 2020-2027
  • Key Issues and Trends Affecting the Market
  • Competitive Outlook
  • Conclusion Highlights

Chapter 2: Introduction

  • Overview
    • Figure 2-1: Coronavirus (COVID-19) 7-Day Case Snapshot Global by Country
    • Table 2-1: Coronavirus (COVID-19) Situation by WHO Region (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific)
    • Figure 2-2: Coronavirus (COVID-19) Cumulative Cases and 7-Day Cases by WHO Region (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, West Pacific)
    • Figure 2-3: Country-Level COVID-19 Cumulative Cases, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
    • Figure 2-4: Country-Level COVID-19 Cumulative Diagnostic Tests Administered, by Country (Australia, Brazil, Canada, France, Germany, India, Indonesia, Italy, Japan, Mexico, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam), Through April 11, 2023
    • Figure 2-5: New Cases vs. Total Cases for Select Countries with Uptick in Cases, by Country (Afghanistan, Austria, Czechia, Hong Kong, Indonesia, Japan, Mexico, Pakistan, Philippines, Poland, Russia, Saudi Arabia, South Korea, Vietnam), April 2023

Chapter 3: Issues and Trends

  • At-Home Testing
    • Figure 3-1: At-Home COVID-19 Test Distribution of Sales, by Vendor (Abbott Diagnostics, Becton Dickinson, OraSure Technologies, Quidel, Siemens Healthineers, Others)
  • Insurance Coverage
  • Multiplex Testing
  • EUAs and Public Health Emergency Expiration
  • New Variants On the Horizon

Chapter 4: COVID-19 Immunoassay Testing

  • Overview
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Mass Spectrometry
  • Rapid
  • Products
  • Antigen
    • Table 4-1: Selected Antigen Immunoassay Tests for SARS-CoV-2
  • Antibody
    • Table 4-2: Selected Antibody Immunoassay EUA Tests for COVID-19
  • Market Size and Growth
    • Table 4-3: Global Immunoassay COVID-19 Testing Market, 2022-2027 $MN; CAGR 2022-2027
    • Table 4-4: Estimated Global Immunoassay COVID-19 Testing Market Distribution by Segment (Antigen, Serology) and End User (Laboratory, Rapid/Near Patient), 2022, (%)
  • Competitive Market Share
    • Figure 4-1: Immunoassay COVID-19 Vendor Market Share, by Vendor (Abbott, Beckman Coulter-Danaher, Becton Dickson, Diasorin, Fujirebio Diagnostics, PerkinElmer, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022 (%)

Chapter 5: COVID-19 Molecular Testing

  • Overview
  • Products
    • Table 5-1: Selected Molecular EUA Tests for COVID-19
  • Market Size and Growth
    • Table 5-2: Estimated Global Molecular COVID-19 Testing Market, 2022-2027 $MN; CAGR 2022-2027
    • Table 5-3: Estimated Global Molecular COVID-19 Testing Market Distribution by End User (Laboratory, Rapid/Near Patient), 2022 (%)
  • Competitive Market Share
    • Figure 5-1: Molecular COVID-19 Vendor Market Share, by Vendor (Abbott, bioMérieux, Cepheid-Danaher, Hologic, Orasure Technologies, PerkinElmer, Qiagen, QuidelOrtho, Roche, ThermoFisher, Others), 2022 (%)

Chapter 6: Total COVID-19 Testing Market Summary

  • Market Overview
    • Table 6-1: Global COVID-19 Testing (Immunoassay, Molecular, Rapid) Sales, by Segment, 2022-2027 ($MN)
    • Figure 6-1: Global IVD Market (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2019-2022, ($MN)
    • Figure 6-2: Global IVD Market, Distribution by Performance Segment (COVID-19 Assays and Instruments, Excluding COVID-19 Assays and Instruments), 2022 (%)
  • Market Segment by Test Type/Site
    • Table 6-2: Global COVID-19 Testing by Test Site (Laboratory, Rapid/Near Patient) Sales by Segment, 2022-2027
    • Figure 6-3: Global COVID-19 IVD Market by Test Site, 2020-2022 and Forecast Through 2027 ($MN)
  • Laboratory Based
    • Table 6-3: Global Lab-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
  • Point of Care
    • Table 6-4: Global Rapid-based COVID-19 Testing Market, Distribution of Sales by Segment (Immunoassay, Molecular), 2022-2027 ($MN)
    • Figure 6-4: Global COVID-19 IVD Market by Test Method, 2020-2022 and Forecast Through 2027 ($MN)
  • Market by Region
    • Figure 6-5: Estimated Global COVID-19 Testing Market by Region (APAC, Europe, North America, Rest of World), 2020-2022
    • Figure 6-6: COVID-19 Testing Market by Country (Australia, Austria, Belgium, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Mexico, Netherlands, Japan, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States), Estimated 2022 ($M)
  • Competitive Analysis
    • Figure 6-7: Top 10 COVID-19 Vendors and Global Market Share, by Vendor (Abbott, bioMérieux, Danaher, Hologic, PerkinElmer, Qiagen, QuidelOrtho, Roche, Siemens, ThermoFisher, Others), 2022

Chapter 7: Selected Market Participants

  • Abbott
    • Table 7-1: Abbott Corporate Summary
  • Company Overview
  • COVID-19
  • Access Bio, Inc
    • Table 7-2: Access Bio Corporate Summary
  • Company Overview
  • COVID-19
  • Becton-Dickinson
    • Table 7-3: Becton-Dickinson Corporate Summary
  • Company Overview
  • COVID-19
  • bioMérieux
    • Table 7-4: bioMérieux Corporate Summary
  • Company Overview
  • COVID-19
  • Bio-Rad
    • Table 7-5: Corporate Summary
  • Company Overview
  • COVID-19
  • Cue Health
    • Table 7-6: Cue Health Corporate Summary
  • Company Overview
  • COVID-19
  • Danaher Corporation
    • Table 7-7: Danaher Corporate Summary
  • Company Overview
  • COVID-19
  • DiaSorin S.p.A.
    • Table 7-8: DiaSorin Corporate Summary
  • Company Overview
  • COVID-19
  • ELITech Group S.A.S.
    • Table 7-9: ELITech Group Corporate Summary
  • Company Overview
  • COVID-19
  • Genedrive plc
    • Table 7-10: Genedrive Corporate Summary
  • Company Overview
  • COVID-19
  • Hologic, Inc
    • Table 7-11: Hologic Corporate Summary
  • Company Overview
  • COVID-19
  • LumiraDx UK Limited
    • Table 7-12: LumiraDx Corporate Summary
  • Company Overview
  • COVID-19
  • OraSure Technologies, Inc.
    • Table 7-13: OraSure Technologies Summary
  • Company Overview
  • COVID-19
  • PerkinElmer, Inc
    • Table 7-14: PerkinElmer Corporate Summary
  • Company Overview
  • COVID-19
  • QIAGEN N.V.
    • Table 7-15: QIAGEN Corporate Summary
  • Company Overview
  • COVID-19
  • QuantuMDx Group, Ltd.
    • Table 7-16: QuantuMDx Corporate Summary
  • Company Overview
  • COVID-19
  • QuidelOrtho Corporation
    • Table 7-17: QuidelOrtho Corporate Summary
  • Company Overview
  • COVID-19
  • Roche Diagnostic Corporation
    • Table 7-18: Roche Diagnostic Corporate Summary
  • Company Overview
  • COVID-19
  • Seegene, Inc
    • Table 7-19: Seegene Corporate Summary
  • Company Overview
  • COVID-19
  • Siemens Healthineers GmbH
    • Table 7-20: Siemens Healthineers Corporate Summary
  • Company Overview
  • COVID-19
  • Snibe Co. Ltd (Shenzhen New Industries Biomedical Engineering Co)
    • Table 7-21: Snibe Corporate Summary
  • Company Overview
  • COVID-19
  • ThermoFisher Scientific
    • Table 7-22: Thermo Fisher Scientific Corporate Summary
  • Company Overview
  • COVID-19
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제